Humacyte (HUMA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

HUMA Humacyte

Watchlist

5.640
+0.020+0.36%

Close Sep 13 16:00 ET

5.650
+0.010+0.18%

Post 20:02 ET

673.14MMarket Cap-4440P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

EF Hutton Initiates Humacyte(HUMA.US) With Buy Rating, Announces Target Price $25
Moomoo NewsSep 9 07:33 ET · Ratings
Benchmark Co. Remains a Buy on Humacyte (HUMA)
TipRanksSep 5 07:36 ET · Ratings
Humacyte to Participate at Upcoming Investor Conferences in September
Yahoo FinanceSep 3 08:00 ET
Both Retail Investors Who Control a Good Portion of Humacyte, Inc. (NASDAQ:HUMA) Along With Institutions Must Be Dismayed After Last Week's 14% Decrease
Simply Wall StAug 31 08:18 ET
Humacyte(HUMA.US) Officer Sells US$5.72 Million in Common Stock
Moomoo NewsAug 29 18:56 ET
Humacyte Reports Positive Results From ATEV Treatment of Vascular Trauma in Ukraine
MT NewswiresAug 27 09:01 ET

Comments

10baggerbamm

Aug 28 06:02

$Humacyte (HUMA.US)$ I know the news hasn't been superb, can always be better...
but the chart looks very very good here..
looks like 9+++ is coming
the options are spread too far apart if they had a $6 strike I think that would make the most sense but they have a 7.50 and to buy it at 60 cents would give you an 8.10 cost basis.. and if we see 9.50 which I think would be like a best case scenario that would yield a 1.40 so I don't think I don't think the options are a good play here because the...

Trytosaveabit

Aug 27 08:09

News

$Humacyte (HUMA.US)$ Humacyte Reports Positive Results From ATEV Treatment of Vascular Trauma in Ukraine
MT Newswires· 5 mins ago
Humacyte (HUMA) on Tuesday reported positive long-term results from its humanitarian program in Ukraine using the investigational acellular tissue engineered vessel, or ATEV, to treat severe vascular injuries.
The long-term data from the V017 trial showed 87.1% primary and secondary patency at 12 months. No infections, amputations, or deaths related to the ATEV wer...

Ddaub

Aug 10 00:12

Who bought that Dip bought hard

$Humacyte (HUMA.US)$ looks like government insiders wanted one more chance to get in first. someone bought that dip hard

frogoracletrading

Aug 9 15:20

$HUMA Support / Resistance Levels

Nasty drop AH. Here are the levels to watch when the dust settles.
Larger Image: tradingview.com...
$Humacyte (HUMA.US)$

Meticulous Trader

Aug 9 15:15

$Humacyte (HUMA.US)$ should have sold when 50% profit now sold around breakeven wasted 23 days hard lesson , never overstaying again in anything 👍all holders

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

HUMA Humacyte

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target